Researchers found that flight attendants show reduced DNA repair capacity and immune changes after air travel, which may help ...

Thermo Fisher Scientific has introduced the Applied Biosystems MagMAX Pro HT NoSpin Plasmid MiniPrep Kit to address the ...

First Trial Site Initiated for Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian Cancer - On May 8, 2025, the Company announced initiation of the first trial site for the OVATION ...

The authors confirm that telomeres in telomerase-positive cells terminate with 5'-ATC in a Pot1-dependent manner, and demonstrate that this principle holds true in telomerase-negative ALT cells as ...

IMNN-001 is the first and only immunotherapy to show meaningful overall survival benefit in a Phase 2 trial in women with advanced ovarian cancer Data from Phase 2 OVATION 2 Study are encouraging, ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

Researchers have developed the Human Intestinal Bacteria Collection (HiBC), comprising 340 gut bacterial strains from 198 ...

Researchers from the University of Birmingham have pinpointed crucial genetic sequences involved in a technique known as ...

A new article titled Self-Documenting Plasmids has been published in Trends in Biotechnology, introducing a breakthrough technology that could redefine the way plasmids are tracked, verified, and ...

Elegen, the leader in next-generation cell-free DNA manufacturing, today announced the early access launch of ENFINIAtm IVT Ready DNA. An expansion of its ENFINIA platform, this new product is ...

Elegen launches Early Access for ENFINIA IVT Ready DNA, complete with a long poly(A) tail, delivered fast & ready for ...